Although these findings are encouraging, additional large-scale, multi-center clinical trials are required to determine standardized BNP cutoff values, enhance its application in clinical practice, and confirm its effectiveness in preventing CIN. This evidence concerns the gene NPPB and cervical squamous intraepithelial neoplasia.